These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 9168989)

  • 1. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
    Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
    Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF.
    Reese TT; Gregory RC; Sharlow ER; Pacifici RE; Crouse JA; Todokoro K; Wojchowski DM
    Growth Factors; 1997; 14(2-3):161-76. PubMed ID: 9255607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
    Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
    Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
    Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
    EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the erythropoietin receptor and involvement of JAK2 in differentiation of J2E erythroid cells.
    Tilbrook PA; Bittorf T; Callus BA; Busfield SJ; Ingley E; Klinken SP
    Cell Growth Differ; 1996 Apr; 7(4):511-20. PubMed ID: 9052992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferative signal transmission mediated by EpoR in leukemic cell lines].
    Fan H; Kanji S; Zhai M
    Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):294-7. PubMed ID: 11876995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
    Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
    Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
    Erickson-Miller CL; Pelus LM; Lord KA
    Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin receptor and STAT5-specific pathways promote SKT6 cell hemoglobinization.
    Gregory RC; Jiang N; Todokoro K; Crouse J; Pacifici RE; Wojchowski DM
    Blood; 1998 Aug; 92(4):1104-18. PubMed ID: 9694697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
    Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
    Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
    Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
    Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line.
    Iwatsuki K; Endo T; Misawa H; Yokouchi M; Matsumoto A; Ohtsubo M; Mori KJ; Yoshimura A
    J Biol Chem; 1997 Mar; 272(13):8149-52. PubMed ID: 9079629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
    Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y
    Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
    Arcasoy MO; Karayal AF
    Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO; Harris KW; Forget BG
    Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells.
    Ammarguellat F; Llovera M; Kelly PA; Goffin V
    Biochem Biophys Res Commun; 2001 Jun; 284(4):1031-8. PubMed ID: 11409898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
    Tilbrook PA; Palmer GA; Bittorf T; McCarthy DJ; Wright MJ; Sarna MK; Linnekin D; Cull VS; Williams JH; Ingley E; Schneider-Mergener J; Krystal G; Klinken SP
    Cancer Res; 2001 Mar; 61(6):2453-8. PubMed ID: 11289114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial polycythemia due to truncations of the erythropoietin receptor.
    Forget BG; Degan BA; Arcasoy MO
    Trans Am Clin Climatol Assoc; 2000; 111():38-44; discussion 44-5. PubMed ID: 10881330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.